India to Jamaica: Pembrolizumab Export Trade Route

The India to Jamaica Pembrolizumab corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $161.5K USD. The route is dominated by SHREE KRISHNA LIFECARE, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's pembrolizumab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $17.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with pembrolizumab's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #15 among India's top pembrolizumab export destinations globally.

On the import side, key buyers of Indian pembrolizumab in Jamaica include KARLENE SMALL, KEISHA YOUNG-HENRY, TERRENCE FORRESTER and 3 others. KARLENE SMALL is the single largest importer with 2 shipments valued at $53.3K USD.

India's pembrolizumab exports to Jamaica are driven primarily by a handful of large-scale manufacturers. SHREE KRISHNA LIFECARE with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Jamaica benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SHREE KRISHNA LIFECARE, KEITA PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $17.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pembrolizumab injection 100mg/4ml (keytruda) (single vial per box) (re-exp.of goods to third country u/s 69) and pembrolizumab injection 100mg/4ml (keytruda) (single vial per box) (re-export ofgoods to third country u/s 69), suggesting that buyers in Jamaica tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KARLENE SMALL is the largest importer with 2 shipments worth $53.3K USD — representing 33% of all pembrolizumab imports from India on this route. A total of 6 buyers are active on this corridor.